Analyses of qRT-PCR and western blotting showed that TMZ treatment increased the expression of CD133, SOX2, OCT4, and NANOG (Figures 1C,D), suggesting that TMZ treatment promotes GSCs formation in GBM cells. Here, PROM1 is linked to glioblastoma.